Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.
about
Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusionEFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION.Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography.Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion.Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion.Direct photocoagulation to leakage points to treat chronic macular edema associated with branch retinal vein occlusion: a pilot study[VEGF inhibitors in vitreoretinal interventions].The ABCs of RVO: a review of retinal venous occlusion.Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study).Full-thickness retinochoroidal incision in the management of central retinal vein occlusionRanibizumab in retinal vein occlusion: treatment recommendations by an expert panelIntravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials.Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment.Retrospective, controlled observational case study of patients with central retinal vein occlusion and initially low visual acuity treated with an intravitreal dexamethasone implant.Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusionMolecular pathogenesis of retinal and choroidal vascular diseases.Association between retinal hemorrhagic pattern and macular perfusion status in eyes with acute branch retinal vein occlusion.Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injectionsNew Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionRetinal oximetry in patients with ischaemic retinal diseases.Short-term efficacy and safety of ranibizumab for macular oedema secondary to retinal vein occlusion in Japanese patients.Reversible retinal vessel closure from VEGF-induced leukocyte plugging.Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion.Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion.Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion“Off-label” use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion.Designing Fcabs: well-expressed and stable high affinity antigen-binding Fc fragments.Predictive factors for recurrence of macular edema after successful intravitreal bevacizumab therapy in branch retinal vein occlusion.Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion.Aflibercept in branch retinal vein occlusion as second line therapy: clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab-a pilot study.Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
P2860
Q24194783-DDD5F87D-E688-4827-82E2-D68FC0596327Q30490419-7F91786B-3834-43BC-A7F5-5B6DE1D90245Q30490830-A24C890B-581A-42A3-84BC-BC72BC2B51C0Q33596694-B543DDB0-1602-47AA-BC59-3C5323D0F952Q33648485-4D4ED706-1AE0-4F3F-99DB-97940A2C6F56Q33828254-5D699182-5363-4CD5-AF8C-5A9D7C35F45CQ34352584-F747E13F-3003-405D-A82F-5D567B9F40DFQ34991648-207A79AE-24AC-41A0-B78D-06D8FC22F8B6Q35047634-870C0978-DCB0-4344-9A7F-9C6E46996276Q35068919-49BA70EB-1A2A-4F00-A9C9-F60851AFDDAFQ35103034-162CE48E-6C9F-4A1A-9315-0E5215CB2B39Q35135745-0AB19E21-7155-43BB-910A-D850FA2A4BE7Q35769968-D0D4CEA8-07A2-4956-A057-6A330263E5DCQ35902075-BE3F2E12-B70C-4C4E-B75A-4749931E3C65Q36175338-C4A5A8C0-4B13-4B35-8CC6-6DA3C6B854C2Q36186327-FC22A23C-4772-48A6-AC59-2434344265A8Q36296789-A72D161E-D46E-4532-A014-C4D03DEA0F66Q37030777-58E47249-29C2-4B9F-99FC-49880F588D90Q37608621-493DC2EA-D7B2-44B6-A00F-66D32CA4856FQ38848800-A0177B05-465F-4A73-B5B8-D54E71DB57B6Q38944073-E2815B07-3AD4-445E-8842-C41E5FBC2060Q40571282-1F084FFC-2A31-4AC9-9E16-F2ED92C8E41CQ42367664-E9ADF6A0-5D67-4467-965B-C5A1BB084F2AQ42372209-BCBC9FCE-0A4D-4DC3-B13D-3FFE4489F39AQ42372246-2602017F-EB50-44D2-A44C-12E557A6835BQ42578593-54E7AEF5-B4CE-4FBF-93FE-D4CD4C679D88Q47140209-1C7CC619-FC9A-4E14-ABFC-046531648D78Q47162242-38F5BDE3-DE4E-4256-A246-C4628286889CQ47597969-A646DE1D-58A6-4B38-884D-54B4AADA072FQ50564863-F66F586F-DD31-4E99-A606-A4D2A54B9A4FQ50592893-CA7124A1-E78E-441A-98D1-ABB561AE49A6Q55073223-47A04B03-15C3-4477-A1BB-701610C9B9EAQ58130274-629B864B-AD35-42E9-8BD0-D0B9FC5E61DC
P2860
Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Vascular endothelial growth fa ...... s with retinal vein occlusion.
@en
Vascular endothelial growth fa ...... s with retinal vein occlusion.
@nl
type
label
Vascular endothelial growth fa ...... s with retinal vein occlusion.
@en
Vascular endothelial growth fa ...... s with retinal vein occlusion.
@nl
prefLabel
Vascular endothelial growth fa ...... s with retinal vein occlusion.
@en
Vascular endothelial growth fa ...... s with retinal vein occlusion.
@nl
P2093
P1433
P1476
Vascular endothelial growth fa ...... s with retinal vein occlusion.
@en
P2093
Howard Shapiro
Peter A Campochiaro
Robert B Bhisitkul
Roman G Rubio
P304
P356
10.1016/J.OPHTHA.2012.09.032
P577
2012-12-20T00:00:00Z